EIKEN CHEMICAL CO.,LTD.

4549

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-30FY2027 Q1

Revenue

424.3100M JPY

YoY +2.9%

Operating Income

6.7100M JPY

YoY -16.6%

Net Income

35.5100M JPY

YoY +51.7%

EPS

13.5JPY

YoY -25.8%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

432.7億円

324.5億円

216.4億円

108.2億円

Rev: 430億円Op: 83.9億円NI: 62.2億円

Rev: 432.7億円Op: 74.6億円NI: 57.4億円

Rev: 400.5億円Op: 33.8億円NI: 26.3億円

Rev: 405.4億円Op: 30億円NI: 22.3億円

Rev: 419億円Op: 29.2億円NI: 37.1億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income21.5%

Revenue Progress107.300M

Revenue Forecast42000M

Net Income Progress4.500M

Net Income Forecast20.700M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan